TIM's management has missed its guidance targets countless times in recent years, so we remain cautious. On top of a more than EUR 4 billion cash cushion after the divestment of its fixed network, TIM ...

Teddy Mutryn is an underrated forward with two-way ability and scoring upside, projected as a mid to late-round pick in the 2025 NHL Draft.

BeiGene aims to be a next-generation oncology innovator by broadening its drug and pipeline portfolio to various solid tumors in addition to blood cancers. As such, it been actively investing to build ...

The U.S. Army Combat Capabilities Development Command, or DEVCOM, wrapped up its 8-month long Science, Technology, And ...

CRISPR Therapeutics faces challenges with a 20% stock drop, slow Casgevy commercialization, and regulatory hurdles. Read more ...

Globant (NYSE: GLOB), a digitally native company focused on reinventing businesses through innovative technology solutions, ...

Today, the U.S. Court of Appeals for the Federal Circuit (CAFC) issued a precedential decision in Incyte Corp. v. Sun ...

With the NFL draft complete, and with the Seahawks getting their first look at the new players, let's look at four veterans ...

AI-powered price tracking can watch your competitors 24/7, notice the second they tweak a price and alert you. It can scan ...

Mike Capone gets at least three calls a week in his suburban Philadelphia office from automakers or suppliers seeking his ...